Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Cognitive Effects of Paliperidone Palmitate vs. Oral Risperidone in First-Episode Schizophrenia

NCT01451736 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT01451736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01451736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Cognitive Effects of Paliperidone Palmitate vs. Oral Risperidone in First-Episode Schizophrenia
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2011
Completion date
December 31, 2021
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia (recent-onset)